glp 1 google scholar Glucagon-like peptide (GLP-1) The Influence of GLP-1 Agonists

Curr Opin Nephrol Hypertens 23:5460 Day JW, Ottaway N, Patterson JT et al (2009) A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

However, more serious issues have also been linked to these drugs, including gallbladder problems, low blood sugar, kidney injury and diabetic retinopathy (damage to the eyes retina)

Phase 3 trial of semaglutide in metabolic dysfunctionassociated steatohepatitis

( reuters.com ( abcnews.go.com ( Health Risks: Alcohol Interaction with GLP-1 Medications Study identifies benefits, risks linked to popular weight-loss drugs | WashU Medicine ( healthyliferecovery.com ( Obesity drugs: huge study identifies new health risks ( medicalnewstoday.com ( jamanetwork.com ( Emerging Research: GLP-1 Medications in Treating Alcohol Use Disorders jamanetwork.com ( abcnews.go.com ( Five things to know about GLP-1s and addiction ( GLP-1 medications: The next big thing in alcohol use disorder treatment

Food noise can take up so much space mentally, says Bedrosian